Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• 1. Immunoadjuvants for cancer immunotherapy2. Nanotechnology as an emerging option in cancer immunotherapy3. Different administration routes for nanovectors in cancer immunotherapy4. Two-dimensional materialbased nanomedicines for cancer immunotherapy5. Hydrogel-based nanomedicines for cancer immunotherapy6. Exosomes-based nanomedicines for cancer immunotherapy7. Lipid-based nanomedicines for cancer immunotherapy8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy9. Liposome-based nanomedicines for cancer immunotherapy10. Biomembrane-based nanoparticles for cancer immunotherapy11. Dendrimer-based nanomedicines for cancer immunotherapy12. Magnetic nanocarriers for cancer immunotherapy13. Inhaled delivery of immunotherapy for treatment of lung cancer14. Nano-based vaccination and their administration routes in cancer immunotherapy15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy